Haemoglobin levels in the chronic dialysis population in the Nephrology Unit at Chris Hani Baragwanath Academic Hospital

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-09-07

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis.

  2014cited by this paper
• Health-related quality of life in patients on hemodialysis and peritoneal dialysis.

  2013cited by this paper
• Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients

  2013cited by this paper
• End-stage renal disease in sub-Saharan Africa.

  2013cited by this paper
• Current status of end-stage renal disease care in India and Pakistan

  2013cited by this paper
• Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country

  2013cited by this paper
• What do we know about chronic kidney disease in India: first report of the Indian CKD registry

  2012cited by this paper
• Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial

  2012cited by this paper
• Hepatitis C Virus Infection and Dialysis: 2012 Update

  2012cited by this paper
• Burden of end-stage renal disease in sub-Saharan Africa.

  2011cited by this paper
• Red blood cell survival in long-term dialysis patients.

  2011cited by this paper
• Regulation of erythropoietin production

  2011cited by this paper
• Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues.

  2011cited by this paper
• Erythropoiesis-stimulating agents in renal medicine.

  2011cited by this paper
• Renal anemia: a nephrologist's view.

  2011cited by this paper
• Lessons to be learned from recent studies of anaemia management in chronic kidney disease

  2011cited by this paper
• Epidemiology of peritoneal dialysis: a story of believers and nonbelievers

  2010cited by this paper
• Emerging erythropoiesis-stimulating agents

  2010cited by this paper
• Inflammation and cachexia in chronic kidney disease

  2010cited by this paper
• The elderly patients on hemodialysis.

  2010cited by this paper
• Optimal Use of Peritoneal Dialysis in Patients with Diabetes

  2009cited by this paper
• A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

  2009cited by this paper
• Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation.

  2009cited by this paper
• The databases: renal replacement therapy since 1989--the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA).

  2009cited by this paper
• Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness

  2009cited by this paper
• Latest Strategy in Renal Anemia Management in Peritoneal Dialysis Patients

  2008cited by this paper
• Erythropoietin stimulating agents in the management of anemia of chronic kidney disease

  2008cited by this paper
• Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

  2008cited by this paper
• Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.

  2008cited by this paper
• Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients.

  2008cited by this paper
• Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure

  2008cited by this paper
• Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations

  2007cited by this paper
• Strategies for the early detec tion and management of chronic kidney disease– tertiary and primary health care working together

  2007cited by this paper
• Peritoneal Dialysis in South Africa- A Single Centre Experience

  2007cited by this paper
• Diabetes, kidney disease and anaemia: time to tackle a troublesome triad?

  2007cited by this paper
• Inflammatory marker mania in chronic kidney disease: pentraxins at the crossroad of universal soldiers of inflammation.

  2007cited by this paper
• KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.

  2007cited by this paper
• Association of initial hemodialysis vascular access with patient-reported health status and quality of life.

  2007cited by this paper
• End-stage renal disease: global demographics in 2005 and observed trends.

  2006cited by this paper
• Inflammatory syndrome in patients on hemodialysis.

  2006cited by this paper
• Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients.

  2006cited by this paper
• Correction of anemia with epoetin alfa in chronic kidney disease.

  2006cited by this paper
• Chronic kidney disease in the developing world.

  2006cited by this paper
• Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.

  2006cited by this paper
• The incidence of end-stage renal disease in India: a population-based study.

  2006cited by this paper
• Anemia in chronic kidney disease: causes, diagnosis, treatment.

  2006cited by this paper
• HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Platelet Dysfunction and End‐Stage Renal Disease

  2006cited by this paper
• Intravenous iron requirement in adult hemodialysis patients

  2006cited by this paper
• Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

  2006cited by this paper
• ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends.

  2005cited by this paper
• Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program.

  2005cited by this paper
• Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects.

  2005cited by this paper
• Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease.

  2005cited by this paper
• The kidneys in the Bible: what happened?

  2005cited by this paper
• The elderly patient with chronic kidney disease.

  2005cited by this paper
• Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.

  2004cited by this paper
• Red blood cell survival in chronic renal failure.

  2004cited by this paper
• Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.

  2004cited by this paper
• Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

  2004cited by this paper
• Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach.

  2004cited by this paper
• Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis.

  2004cited by this paper
• Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.

  2003cited by this paper
• End-stage renal disease in sub-Saharan and South Africa.

  2003cited by this paper
• Sir Robert Christison (1797-1882): a neglected founder of nephrology.

  2003cited by this paper
• Tuberculosis and Chronic Renal Disease

  2003cited by this paper
• Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994).

  2002cited by this paper
• Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life.

  2002cited by this paper
• clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification

  2002cited by this paper
• Anaemia of chronic kidney disease: an under-recognized and under-treated problem.

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• An African community-based chronic ambulatory peritoneal dialysis programme.

  2001cited by this paper
• IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

  2001cited by this paper
• Quality of life in end-stage renal disease patients.

  2001cited by this paper
• Erythropoietin and anemia.

  2001cited by this paper
• Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency.

  2001cited by this paper
• Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level.

  2001cited by this paper
• Towards the millennium: a history of renal anaemia and the optimal use of epoetin.

  1999cited by this paper
• European best practice guidelines for the management of anaemia in patients with chronic renal failure.

  1999cited by this paper
• Acute-phase proteins and other systemic responses to inflammation.

  1999cited by this paper
• Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group.

  1999cited by this paper
• Twelve centuries of nephrological writings in the Graeco-Roman world of the Eastern Mediterranean (from Hippocrates to Aetius Amidanus).

  1999cited by this paper
• High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients.

  1997cited by this paper
• High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition.

  1997cited by this paper
• The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting Enzyme (*)

  1995cited by this paper
• Inhibitory peptides in hematopoiesis.

  1995cited by this paper
• Identification of the renal erythropoietin-producing cells using transgenic mice.

  1993cited by this paper
• Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population.

  1993cited by this paper
• The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.

  1991cited by this paper
• Development of a new radioimmunoassay for erythropoietin using recombinant erythropoietin.

  1990cited by this paper
• Hypertension as a cause of end-stage renal failure in South Africa.

  1990cited by this paper
• Recombinant human erythropoietin: implications for nephrology.

  1988cited by this paper
• The Story of Nephrology 1

  1980cited by this paper
• Anemia and secondary hyperparathyroidism.

  1978cited by this paper

• No citing papers are available for this paper.